Pfizer Halts Cholesterol Drug Trials

Pfizer said Saturday it has cut off all clinical trials and development for a cholesterol drug th...  More »

Pfizer said Saturday it has cut off all clinical trials and development for a cholesterol drug that was supposed to be the star of its pipeline because of an unexpected number of deaths and cardiovascular problems in patients who used it. (Dec. 3)  « Less